Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
Philanthropist Arthur Blank pledges $2.5M for Jamaica's hurricane relief efforts as the island faces catastrophic damage and ongoing recovery needs.
Novo Nordisk launches a rival $56.50 bid to acquire U.S. obesity biotech Metsera, challenging Pfizer's existing agreement and sparking a bidding war over Metsera's promising GLP-1 pipeline.
Altria's Q3 earnings beat estimates, but shares fell on a weak outlook and persistent category challenges.
Philanthropist Arthur Blank pledges $2.5M for Jamaica's hurricane relief efforts as the island faces catastrophic damage and ongoing recovery needs.
